Related Experiment Video
Updated: May 6, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine
M C Stühlinger1, P S Tsao, J H Her
1Section of Vascular Medicine, Stanford University, Stanford, California, USA.
Insights
High homocysteine levels increase asymmetric dimethylarginine (ADMA) by inhibiting its degrading enzyme, DDAH. This finding explains how homocysteine impairs blood vessel function and nitric oxide synthesis.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Molecular Biology
Background:
- Hyperhomocysteinemia is linked to cardiovascular disease and impaired endothelium-dependent vasodilation.
- Elevated asymmetric dimethylarginine (ADMA) is a potential mechanism for cardiovascular risk factors affecting vascular function.
- ADMA is an endogenous inhibitor of nitric oxide synthase (NOS).
Purpose of the Study:
- To investigate whether homocysteine can increase ADMA levels.
- To elucidate the mechanism by which homocysteine might affect ADMA.
Main Methods:
- Exposure of endothelial and nonvascular cells to DL-homocysteine or L-methionine.
- Measurement of ADMA concentration in cell culture medium.
- Assessment of dimethylarginine dimethylaminohydrolase (DDAH) activity.
- Evaluation of nitric oxide synthesis in endothelial cells and aortic segments.
- In vitro studies using recombinant human DDAH.
Main Results:
- Homocysteine increased ADMA levels in a dose- and time-dependent manner.
- This increase in ADMA was associated with reduced DDAH activity.
- Homocysteine-induced ADMA accumulation led to decreased nitric oxide synthesis.
- Pyrrolidine dithiocarbamate partially reversed these effects.
- Homocysteine directly inhibited recombinant human DDAH activity.
Conclusions:
- Homocysteine post-translationally inhibits DDAH enzyme activity.
- This inhibition causes ADMA accumulation, which in turn inhibits nitric oxide synthesis.
- The study provides a molecular mechanism for homocysteine's adverse effects on endothelium-mediated vasodilation.
Background:
Hyperhomocysteinemia is a putative risk factor for cardiovascular disease, which also impairs endothelium-dependent vasodilatation. A number of other risk factors for cardiovascular disease may exert their adverse vascular effects in part by elevating plasma levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase. Accordingly, we determined if homocysteine could increase ADMA levels.
Methods And Results:
When endothelial or nonvascular cells were exposed to DL-homocysteine or to its precursor L-methionine, ADMA concentration in the cell culture medium increased in a dose- and time-dependent fashion. This effect was associated with the reduced activity of dimethylarginine dimethylaminohydrolase (DDAH), the enzyme that degrades ADMA. Furthermore, homocysteine-induced accumulation of ADMA was associated with reduced nitric oxide synthesis by endothelial cells and segments of pig aorta. The antioxidant pyrrollidine dithiocarbamate preserved DDAH activity and reduced ADMA accumulation. Moreover, homocysteine dose-dependently reduced the activity of recombinant human DDAH in a cell free system, an effect that was due to a direct interaction between homocysteine and DDAH.
Conclusion:
Homocysteine post-translationally inhibits DDAH enzyme activity, causing ADMA to accumulate and inhibit nitric oxide synthesis. This may explain the known effect of homocysteine to impair endothelium-mediated nitric oxide-dependent vasodilatation.
More Related Videos
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
05:57Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
Published on: April 26, 2024
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Nitric Oxide Signaling Pathway
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Sulfur Assimilation
Biosynthesis of Nucleic Acids